ASSESSMENT AND INTERVENTION FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN THE SCHOOLS : Lessons from the MTA Study† - 07/09/11
Résumé |
At the conclusion of the recent National Institutes of Health (NIH) Consensus Conference18 on attention-deficit/hyperactivity disorder (ADHD),1 the consensus panel made two interesting observations about school-based assessments and interventions for ADHD. About assessment, the panel observed that “… there appears to be a `disconnect' between developmental or educational (school-based) assessments and health-related (physician-based) services.” About intervention, the panel observed that “There is often poor communication between diagnosticians and those who implement and monitor treatment in the schools.” What are these deficiencies and how can we overcome them? To address these questions, we draw on some of our research experiences in the Multimodality Treatment of ADHD (MTA) study, a national research project of the National Institute of Mental Health and the US Department of Education.4, 9, 12, 16, 17, 22
The MTA study brought together pediatricians (represented here by ML), psychiatrists (represented here by JM), and psychologists and educators (represented here by FG), who devoted approximately a decade to propose, design, and implement a randomized clinical trial of multimodality treatment of ADHD, including both pharmacologic and behavioral interventions. Our review of the literature and our experiences in the historic research study suggest why a “disconnect” might exist between clinicians and educators during the assessment of children suspected of having ADHD. Based on these experiences and the literature, we offer some ideas about how clinicians might improve communication with educators who implement and maintain intervention in the schools.
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to James Swanson, PhD, UC Irvine Child Development Center, 19722 MacArthur Boulevard, Irvine, CA 92612 |
|
| † | The MTA Subgroup: Laurence Greenhill, MD; Steve Hinshaw, PhD; Howard Abikoff, PhD; William Pelham, PhD; Peter Jensen, MD; Ellen Shiller, PhD; Sabrina Schuck, MA; Steve Simpson, MA; Tim Wigal, PhD; Lillie Williams, MD; Joanne Severe, MA; and Walter Clevenger, BA. |
Vol 46 - N° 5
P. 993-1009 - octobre 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
